Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high-performing health systems: the adherence and intensification of medications cluster randomized, controlled pragmatic trial.

dc.contributor.author

Heisler, Michele

dc.contributor.author

Hofer, Timothy P

dc.contributor.author

Schmittdiel, Julie A

dc.contributor.author

Selby, Joe V

dc.contributor.author

Klamerus, Mandi L

dc.contributor.author

Bosworth, Hayden B

dc.contributor.author

Bermann, Martin

dc.contributor.author

Kerr, Eve A

dc.date.accessioned

2024-02-01T16:45:57Z

dc.date.available

2024-02-01T16:45:57Z

dc.date.issued

2012-06

dc.description.abstract

Background

Even in high-performing health systems, some patients with diabetes mellitus have poor blood pressure (BP) control because of poor medication adherence and lack of medication intensification. We examined whether the Adherence and Intensification of Medications intervention, a pharmacist-led intervention combining elements found in efficacy studies to lower BP, improved BP among patients with diabetes mellitus with persistent hypertension and poor refill adherence or insufficient medication intensification in 2 high-performing health systems.

Methods and results

We conducted a prospective, multisite cluster randomized pragmatic trial with randomization of 16 primary care teams at 5 medical centers (3 Veterans Affairs and 2 Kaiser Permanente) to the Adherence and Intensification of Medications intervention or usual care. The primary outcome was relative change in systolic BP (SBP), comparing 1797 intervention with 2303 control team patients, from 6 months preceding to 6 months after the 14-month intervention period. We examined shorter-term changes in SBP as a secondary outcome. The mean SBP decrease from 6 months before to 6 months after the intervention period was ≈9 mm Hg in both arms. Mean SBPs of eligible intervention patients were 2.4 mm Hg lower (95% CI: -3.4 to -1.5; P<0.001) immediately after the intervention than those achieved by control patients.

Conclusions

The Adherence and Intensification of Medications program more rapidly lowered SBPs among intervention patients, but usual-care patients achieved equally low SBP levels by 6 months after the intervention period. These findings show the importance of evaluating in different real-life clinical settings programs found in efficacy trials to be effective before urging their widespread adoption in all settings.

Clinical trial registration

URL: http://clinicaltrials.gov. Unique identifier: NCT00495794.
dc.identifier

CIRCULATIONAHA.111.089169

dc.identifier.issn

0009-7322

dc.identifier.issn

1524-4539

dc.identifier.uri

https://hdl.handle.net/10161/30050

dc.language

eng

dc.publisher

Ovid Technologies (Wolters Kluwer Health)

dc.relation.ispartof

Circulation

dc.relation.isversionof

10.1161/circulationaha.111.089169

dc.rights.uri

https://creativecommons.org/licenses/by-nc/4.0

dc.subject

Humans

dc.subject

Hypertension

dc.subject

Diabetes Complications

dc.subject

Antihypertensive Agents

dc.subject

Hypoglycemic Agents

dc.subject

Treatment Outcome

dc.subject

Follow-Up Studies

dc.subject

Prospective Studies

dc.subject

Program Evaluation

dc.subject

Risk Reduction Behavior

dc.subject

Counseling

dc.subject

Blood Pressure

dc.subject

Aged

dc.subject

Middle Aged

dc.subject

Pharmacists

dc.subject

Veterans

dc.subject

Health Maintenance Organizations

dc.subject

Primary Health Care

dc.subject

Patient Care Team

dc.subject

Female

dc.subject

Male

dc.subject

Medication Adherence

dc.title

Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high-performing health systems: the adherence and intensification of medications cluster randomized, controlled pragmatic trial.

dc.type

Journal article

duke.contributor.orcid

Bosworth, Hayden B|0000-0001-6188-9825

pubs.begin-page

2863

pubs.end-page

2872

pubs.issue

23

pubs.organisational-group

Duke

pubs.organisational-group

School of Medicine

pubs.organisational-group

Basic Science Departments

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Medicine

pubs.organisational-group

Psychiatry & Behavioral Sciences

pubs.organisational-group

Medicine, General Internal Medicine

pubs.organisational-group

Duke Cancer Institute

pubs.organisational-group

Duke Clinical Research Institute

pubs.organisational-group

Institutes and Provost's Academic Units

pubs.organisational-group

Center for the Study of Aging and Human Development

pubs.organisational-group

Initiatives

pubs.organisational-group

Duke Science & Society

pubs.organisational-group

Population Health Sciences

pubs.organisational-group

Duke Innovation & Entrepreneurship

pubs.organisational-group

Psychiatry & Behavioral Sciences, Behavioral Medicine & Neurosciences

pubs.organisational-group

Duke - Margolis Center For Health Policy

pubs.publication-status

Published

pubs.volume

125

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high.pdf
Size:
904.2 KB
Format:
Adobe Portable Document Format